Target intelligence / Profile preview

Immunoglobulin heavy diversity 1-7 (IGHD1-7)

Target: IGHD1-7
Molecular classification: Other (Immunoglobulin gene segment)

Overview

Immunoglobulin heavy diversity 1-7 (IGHD1-7) is one of several diversity (D) gene segments within the immunoglobulin heavy-chain locus on chromosome 14q32, required for generating variable regions of antibodies through V(D)J recombination during B cell development[2][3]. The V, D, and J segments recombine to produce unique immunoglobulin heavy chains, critical for immune diversity. IGHD1-7 itself is not a functional protein or receptor but is a short DNA segment used in generating B cell receptor (antibody) diversity. Errors or aberrant recombination may contribute to lymphoid malignancies, but IGHD1-7 is not a direct therapeutic or diagnostic target.

Other names: IGHD1-7DM1 (not applicable; likely incorrect in this context)IGHD17 (possible confusion or alternate segment naming, but not standard)

Mechanism of action

Null (Not druggable; its biological role is in V(D)J recombination)

Biological functions

Immune response (generation of antibody diversity)

Disease associations

Null (No direct role as causative or therapeutic target; somatic rearrangement errors may contribute to immunodeficiency or lymphoid malignancies, but IGHD1-7 is not an actionable target)

Safety considerations

Null (No safety concerns reported for IGHD1-7 specifically)

Interacting drugs

Null (No drugs interact directly with IGHD1-7)

Biomarkers

Null (Rarely, immunoglobulin gene rearrangements are used as lymphoid malignancy markers, but IGHD1-7 itself is not specific as a biomarker)

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 1-7 (IGHD1-7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 1-7 (IGHD1-7).

Explore the full profile